Santarus, Inc. (NASDAQ:SNTS) will speak at the Piper Jaffray Health Care Conference on Wednesday, December 2. The 21st annual conference will be held at the Palace Hotel in New York City. The company’s presentation will begin at 12:30 pm ET that afternoon. The presentation will be hosted by Santarus President and chief Executive Officer Gerald Proehl.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Santarus, Inc. (Santarus) is a specialty pharmaceutical company focused on acquiring, developing and commercializing products that address the needs of patients treated by gastroenterologists or primary care physicians. Santarus focuses on commercializing of its Zegerid immediate-release proton pump inhibitor (PPI) products. PPI products are used for the treatment of many upper gastrointestinal (GI) diseases and disorders, including gastroesophageal reflux disease (GERD). The Company’s Zegerid products are immediate-release formulations that combine omeprazole, a PPI, and one or more antacids.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
